Skip to main content
Jonathan Katz, MD, Neurology, San Francisco, CA

Jonathan S Katz MD

Neurophysiology


Neurologist, Sutter Pacific Medical Foundation Forbes-Norris MDA/ALS

Join to view full profile
  • 2324 Sacramento StSte 111San Francisco, CA 94115

  • Phone+1 415-600-3604

  • Fax+1 415-673-5184

Dr. Katz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Washington
    University of WashingtonResidency, Neurology, 1989 - 1992
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - 2027
  • TX State Medical License
    TX State Medical License 1993 - 1995
  • WA State Medical License
    WA State Medical License 1989 - 1994
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
  • CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2014-2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Former Chiropractic Employees Describe What They Say Happened Behind the Scenes at Superior Health Centers
    Former Chiropractic Employees Describe What They Say Happened Behind the Scenes at Superior Health CentersSeptember 14th, 2021
  • Peace over Promise: ALS Patient Quits Taking Drug Aimed at Slowing Disease
    Peace over Promise: ALS Patient Quits Taking Drug Aimed at Slowing DiseaseMarch 8th, 2019
  • First FDA-Approved Treatment for ALS in 22 Years Now Available in U.S.
    First FDA-Approved Treatment for ALS in 22 Years Now Available in U.S.August 8th, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: